Teva Wins Ban On Mylan Parkinson's Generic
A New Jersey federal judge on Friday barred Mylan Inc. from manufacturing, importing or selling its own version of Teva Pharmaceutical Industries Ltd.'s brand-name treatment for Parkinson's disease, Azilect, for more...To view the full article, register now.
Already a subscriber? Click here to view full article